Allied Market Research
Loading...
0
New
New
2022

Neuromonitoring Devices Market by Product (Intracranial Pressure Monitoring, Cerebral Oximeter, Near Infrared Spectroscopy, Speckle Imaging, Doppler Ultrasound, EEG, Fetal/Neonatal Neuro-Monitoring Devices, Micro Ultrasound, Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

A16606
Pages: 175
Jun 2022 | 171 Views
   
Author(s) : Pankaj Darbarsingh Jadhav, Neha Mittal , Vitika Verma
Tables: 49
Charts: 54
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the

Request Now !

Neuromonitoring Devices Market Research, 2030

The global neuromonitoring devices market was valued at $5.6 billion in 2021, and is projected to reach $10.3 billion by 2030, growing at a CAGR of 7.24% from 2022 to 2030.

The COVID-19 pandemic has severely affected the business sector, across the world. During the pandemic, where healthcare sector experienced a positive growth, neuromonitoring devices market experienced a major setback due to decreased demand in the hospitals and clinics

Neuromonitoring Devices Market, Neuromonitoring Devices Market size, Neuromonitoring Devices Market share, Neuromonitoring Devices Market trends, Neuromonitoring Devices Market growth, Neuromonitoring Devices Market analysis, Neuromonitoring Devices Market forecast, Neuromonitoring Devices Market opportunity

Get more information on this report : Request Sample Pages

The neuromonitoring devices market is segmented into and Product.

Neuromonitoring is the monitoring of central and peripheral nervous system neurophysiological functions during surgical procedures. Thus, is expected to drive the Neuromonitoring Devices market share. In the field of medicine, technology has advanced significantly, with newer and more complex technologies being developed to assist physicians in their daily practices. Many of these devices have become less invasive or noninvasive in recent years. Such is the situation with neuromonitoring device's market size, where multimodality noninvasive monitoring may now be used to extract a wealth of information useful for both therapeutic and predictive purposes.

Neuromonitoring devices are medical devices that can display or monitor the vital signs of a patient's brain by recording data such as electrical impulse rate, blood flow, and oxygen level and display the results instantly. These devices are commonly used in hospitals, clinics, and other similar settings. There are several types of neuromonitoring devices in the market including doppler ultrasound, computed tomography (CT scan), and magnetic resonance imaging (MRI).

Increasing medical tourism is a major trend for neuromonitoring products and service providers as spine surgery is one of the fastest-growing specialties in medical tourism. Using neuromonitoring as part of medical tourism would improve surgery results all around the world. Patients who travel for medical treatment frequently function as both consumers and decision-makers. As a result, the need for neuromonitoring devices in hospitals may increase as a result of increased demand from medical tourism patients. Furthermore, medical tourism would raise knowledge about the need of  neuromonitoring and how to use it during surgeries. 

The rising prevalence of neurological diseases such as epilepsy, Parkinson's disease, and Alzheimer's disease, particularly among the geriatric population, is expected to drive the global market for neuromonitoring devices. The growing prevalence of neurological diseases, the emergence of neurodegenerative disorders, the increase in the number of brain injuries, and the recent expansion of brain tracking in clinical studies will drive the neuromonitoring devices market opportunity over the forecast period..

However, the high cost of neuromonitoring devices, as well as a scarcity of skilled technicians and personnel, are expected to stymie market growth. Furthermore, there is a scarcity of qualified professionals for device performance and high process costs associated with neuromonitoring devices deployment, which are expected to present a challenge to the market expansion of neuromonitoring devices all through the period of analysis.

The global neuromonitoring devices market is segmented on the basis of product and region. By product, the market is classified into intracranial pressure monitoring, cerebral oximeter, near infrared spectroscopy, speckle imaging, doppler ultrasound, EEG, fetal/neonatal neuromonitoring devices, micro ultrasound, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players profiled in this report include GE Healthcare, Koninklijke Philips N.V., Medtronic Plc, Nihon Kohden Corporation, Natus Medical Incorporated., Nuvasive, Inc., Advanced Brain Monitoring, Inc., Intranerve Neuroscience Holdings, Llc, Specialtycare, and RIMED Ltd.

Neuromonitoring Devices Market
By Product

Your browser does not support the canvas element.

Doppler Ultrasound sub-segment dominated the global market in 2021

By product, doppler ultrasound sub-segment is projected to generate the maximum revenue during the forecast period. Doppler ultrasounds employ sound waves to create images of how blood flows through veins and arteries in the body. Often, the purpose is to check blood flow in the arms and legs. A handheld instrument creates sound waves that bounce off moving things like blood cells during a doppler ultrasonography. The reflected sound waves generate a representation of blood flow. The growth is attributed to increasing cases of neurological disorders among people of all age groups, especially geriatric population. These factors are anticipated to propel the neuromonitoring devices market growth in the recent years.

By region, North America dominated the global neuromonitoring devices market in 2021. The growth is attributed to the rising demand for better and advanced healthcare facilities among patients. Also, adoption of new and advanced technologies might further increase the market revenue of North America. Major market players have focused on launching new products in the market to cater the rising demand for neuromonitoring devices amid rising cases of neurological disorders such as epilepsy.The Asia-Pacific region is expected to grow at a healthy pace. Over the projected period, emerging economies such as Japan, China, South Korea, and India are expected to rise significantly. The existence of a number of local players in China and Japan could help the industry flourish. Furthermore, the local market is likely to be driven by the growing senior population and the rising prevalence of traumatic brain injuries in the approaching years. According to national 2020 census predictions, b By 2025, China country's old population is predicted to reach 300 million, and by 2033, it will surpass 400 million.

Neuromonitoring Devices Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific is expected to grow with the highest CAGR during the forecast period.

    IMPACT OF COVID-19 ON THE GLOBAL NEUROMONITORING DEVICES MARKET

    • The COVID-19 pandemic has severely affected the business sector, across the world. During the pandemic, where healthcare sector experienced a positive growth, neuromonitoring devices market experienced a major setback due to decreased demand in the hospitals and clinics.
    • Since the coronavirus is highly transmissible, several hospitals’ authorities restricted the admission of patients with other diseases and this factor has decreased the demand for neuromonitoring devices.
    • Also, many neurosurgeries were postponed amid rising cases of coronavirus patients. This factor is further likely to impede the market growth in the pandemic duration.

    Key Benefits For Stakeholders

    • This analysis provides indepth analysis regarding neuromonitoring devices market size, market segments, current trends, estimations, and dynamics of the neuromonitoring devices market analysis from 2021 to 2030 to identify the prevailing neuromonitoring devices market opportunities.
    • The market research is offered along with information related to key drivers, restraints, and opportunities.
    • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
    • In-depth analysis of the neuromonitoring devices market forecast on the basis of segmentation that assists to determine the prevailing market opportunities.
    • Major countries in each region are mapped according to their revenue contribution to the global market.
    • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
    • The report includes the analysis of the regional as well as global neuromonitoring devices market trends, key players, market segments, application areas, and market growth strategies.

    Key Market Segments

    • By Product
      • Intracranial Pressure Monitoring
      • Cerebral Oximeter
      • Near Infrared Spectroscopy
      • Speckle Imaging
      • Doppler Ultrasound
      • EEG
      • Fetal/Neonatal Neuro-Monitoring Devices
      • Micro Ultrasound
      • Others
    • By Region
      • North America
        • U.S.
        • Canada
        • Mexico
      • Europe
        • Germany
        • United Kingdom
        • France
        • Spain
        • Italy
        • Rest of Europe
      • Asia-Pacific
        • China
        • Japan
        • India
        • South Korea
        • Australia
        • Rest Of Asia Pacific
      • LAMEA
        • Brazil
        • Saudi Arabia
        • UAE
        • South Africa
        • Rest of LAMEA
     
    • CHAPTER 1:INTRODUCTION

      • 1.1.Report description

      • 1.2.Key market segments

      • 1.3.Key benefits to the stakeholders

      • 1.4.Research Methodology

        • 1.4.1.Secondary research

        • 1.4.2.Primary research

        • 1.4.3.Analyst tools and models

    • CHAPTER 2:EXECUTIVE SUMMARY

      • 2.1.Key findings of the study

      • 2.2.CXO Perspective

    • CHAPTER 3:MARKET OVERVIEW

      • 3.1.Market definition and scope

      • 3.2.Key findings

        • 3.2.1.Top investment pockets

      • 3.3.Porter’s five forces analysis

      • 3.4.Top player positioning

      • 3.5.Market dynamics

        • 3.5.1.Drivers

        • 3.5.2.Restraints

        • 3.5.3.Opportunities

      • 3.6.COVID-19 Impact Analysis on the market

      • 3.7.Regulatory Guidelines

      • 3.8.Value Chain Analysis

      • 3.9.Market Share Analysis

      • 3.10.Key Regulation Analysis

      • 3.11.Patent Landscape

    • CHAPTER 4: NEUROMONITORING DEVICES MARKET, BY PRODUCT

      • 4.1 Overview

        • 4.1.1 Market size and forecast

      • 4.2 Intracranial Pressure Monitoring

        • 4.2.1 Key market trends, growth factors and opportunities

        • 4.2.2 Market size and forecast, by region

        • 4.2.3 Market analysis by country

      • 4.3 Cerebral Oximeter

        • 4.3.1 Key market trends, growth factors and opportunities

        • 4.3.2 Market size and forecast, by region

        • 4.3.3 Market analysis by country

      • 4.4 Near Infrared Spectroscopy

        • 4.4.1 Key market trends, growth factors and opportunities

        • 4.4.2 Market size and forecast, by region

        • 4.4.3 Market analysis by country

      • 4.5 Speckle Imaging

        • 4.5.1 Key market trends, growth factors and opportunities

        • 4.5.2 Market size and forecast, by region

        • 4.5.3 Market analysis by country

      • 4.6 Doppler Ultrasound

        • 4.6.1 Key market trends, growth factors and opportunities

        • 4.6.2 Market size and forecast, by region

        • 4.6.3 Market analysis by country

      • 4.7 EEG

        • 4.7.1 Key market trends, growth factors and opportunities

        • 4.7.2 Market size and forecast, by region

        • 4.7.3 Market analysis by country

      • 4.8 Fetal/Neonatal Neuro-Monitoring Devices

        • 4.8.1 Key market trends, growth factors and opportunities

        • 4.8.2 Market size and forecast, by region

        • 4.8.3 Market analysis by country

      • 4.9 Micro Ultrasound

        • 4.9.1 Key market trends, growth factors and opportunities

        • 4.9.2 Market size and forecast, by region

        • 4.9.3 Market analysis by country

      • 5.0 Others

        • 5.0.1 Key market trends, growth factors and opportunities

        • 5.0.2 Market size and forecast, by region

        • 5.0.3 Market analysis by country

    • CHAPTER 5: NEUROMONITORING DEVICES MARKET, BY REGION

      • 5.1 Overview

        • 5.1.1 Market size and forecast

      • 5.2 North America

        • 5.2.1 Key trends and opportunities

        • 5.2.2 North America Market size and forecast, by Product

        • 5.2.3 North America Market size and forecast, by country

          • 5.2.3.1 U.S.
            • 5.2.3.1.1 Market size and forecast, by Product
          • 5.2.3.2 Canada
            • 5.2.3.2.1 Market size and forecast, by Product
          • 5.2.3.3 Mexico
            • 5.2.3.3.1 Market size and forecast, by Product
      • 5.3 Europe

        • 5.3.1 Key trends and opportunities

        • 5.3.2 Europe Market size and forecast, by Product

        • 5.3.3 Europe Market size and forecast, by country

          • 5.3.3.1 Germany
            • 5.3.3.1.1 Market size and forecast, by Product
          • 5.3.3.2 United Kingdom
            • 5.3.3.2.1 Market size and forecast, by Product
          • 5.3.3.3 France
            • 5.3.3.3.1 Market size and forecast, by Product
          • 5.3.3.4 Spain
            • 5.3.3.4.1 Market size and forecast, by Product
          • 5.3.3.5 Italy
            • 5.3.3.5.1 Market size and forecast, by Product
          • 5.3.3.6 Rest of Europe
            • 5.3.3.6.1 Market size and forecast, by Product
      • 5.4 Asia-Pacific

        • 5.4.1 Key trends and opportunities

        • 5.4.2 Asia-Pacific Market size and forecast, by Product

        • 5.4.3 Asia-Pacific Market size and forecast, by country

          • 5.4.3.1 China
            • 5.4.3.1.1 Market size and forecast, by Product
          • 5.4.3.2 Japan
            • 5.4.3.2.1 Market size and forecast, by Product
          • 5.4.3.3 India
            • 5.4.3.3.1 Market size and forecast, by Product
          • 5.4.3.4 South Korea
            • 5.4.3.4.1 Market size and forecast, by Product
          • 5.4.3.5 Australia
            • 5.4.3.5.1 Market size and forecast, by Product
          • 5.4.3.6 Rest Of Asia Pacific
            • 5.4.3.6.1 Market size and forecast, by Product
      • 5.5 LAMEA

        • 5.5.1 Key trends and opportunities

        • 5.5.2 LAMEA Market size and forecast, by Product

        • 5.5.3 LAMEA Market size and forecast, by country

          • 5.5.3.1 Brazil
            • 5.5.3.1.1 Market size and forecast, by Product
          • 5.5.3.2 Saudi Arabia
            • 5.5.3.2.1 Market size and forecast, by Product
          • 5.5.3.3 UAE
            • 5.5.3.3.1 Market size and forecast, by Product
          • 5.5.3.4 South Africa
            • 5.5.3.4.1 Market size and forecast, by Product
          • 5.5.3.5 Rest of LAMEA
            • 5.5.3.5.1 Market size and forecast, by Product
    • CHAPTER 6: COMPANY LANDSCAPE

      • 6.1. Introduction

      • 6.2. Top winning strategies

      • 6.3. Product Mapping of Top 10 Player

      • 6.4. Competitive Dashboard

      • 6.5. Competitive Heatmap

      • 6.6. Key developments

    • CHAPTER 7: COMPANY PROFILES

      Note: Details on financial performance and strategic moves and developments may not be captured for unlisted companies.

    • LIST OF TABLES

    • TABLE 1. GLOBAL NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 2. NEUROMONITORING DEVICES MARKET REVENUE, FOR INTRACRANIAL PRESSURE MONITORING, BY REGION , 2021-2030,($MILLION)
      TABLE 3. NEUROMONITORING DEVICES MARKET FOR INTRACRANIAL PRESSURE MONITORING BY COUNTRY, 2021-2030,($MILLION)
      TABLE 4. NEUROMONITORING DEVICES MARKET REVENUE, FOR CEREBRAL OXIMETER, BY REGION , 2021-2030,($MILLION)
      TABLE 5. NEUROMONITORING DEVICES MARKET FOR CEREBRAL OXIMETER BY COUNTRY, 2021-2030,($MILLION)
      TABLE 6. NEUROMONITORING DEVICES MARKET REVENUE, FOR NEAR INFRARED SPECTROSCOPY, BY REGION , 2021-2030,($MILLION)
      TABLE 7. NEUROMONITORING DEVICES MARKET FOR NEAR INFRARED SPECTROSCOPY BY COUNTRY, 2021-2030,($MILLION)
      TABLE 8. NEUROMONITORING DEVICES MARKET REVENUE, FOR SPECKLE IMAGING, BY REGION , 2021-2030,($MILLION)
      TABLE 9. NEUROMONITORING DEVICES MARKET FOR SPECKLE IMAGING BY COUNTRY, 2021-2030,($MILLION)
      TABLE 10. NEUROMONITORING DEVICES MARKET REVENUE, FOR DOPPLER ULTRASOUND, BY REGION , 2021-2030,($MILLION)
      TABLE 11. NEUROMONITORING DEVICES MARKET FOR DOPPLER ULTRASOUND BY COUNTRY, 2021-2030,($MILLION)
      TABLE 12. NEUROMONITORING DEVICES MARKET REVENUE, FOR EEG, BY REGION , 2021-2030,($MILLION)
      TABLE 13. NEUROMONITORING DEVICES MARKET FOR EEG BY COUNTRY, 2021-2030,($MILLION)
      TABLE 14. NEUROMONITORING DEVICES MARKET REVENUE, FOR FETAL/NEONATAL NEURO-MONITORING DEVICES, BY REGION , 2021-2030,($MILLION)
      TABLE 15. NEUROMONITORING DEVICES MARKET FOR FETAL/NEONATAL NEURO-MONITORING DEVICES BY COUNTRY, 2021-2030,($MILLION)
      TABLE 16. NEUROMONITORING DEVICES MARKET REVENUE, FOR MICRO ULTRASOUND, BY REGION , 2021-2030,($MILLION)
      TABLE 17. NEUROMONITORING DEVICES MARKET FOR MICRO ULTRASOUND BY COUNTRY, 2021-2030,($MILLION)
      TABLE 18. NEUROMONITORING DEVICES MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2030,($MILLION)
      TABLE 19. NEUROMONITORING DEVICES MARKET FOR OTHERS BY COUNTRY, 2021-2030,($MILLION)
      TABLE 20. NEUROMONITORING DEVICES MARKET, BY REGION, 2021-2030,($MILLION)
      TABLE 21. NORTH AMERICA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 22. NORTH AMERICA NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2021-2030,($MILLION)
      TABLE 23. U.S. NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 24. CANADA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 25. MEXICO NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 26. EUROPE NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 27. EUROPE NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2021-2030,($MILLION)
      TABLE 28. GERMANY NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 29. UNITED KINGDOM NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 30. FRANCE NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 31. SPAIN NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 32. ITALY NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 33. REST OF EUROPE NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 34. ASIA-PACIFIC NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 35. ASIA-PACIFIC NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2021-2030,($MILLION)
      TABLE 36. CHINA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 37. JAPAN NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 38. INDIA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 39. SOUTH KOREA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 40. AUSTRALIA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 41. REST OF ASIA PACIFIC NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 42. LAMEA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 43. LAMEA NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2021-2030,($MILLION)
      TABLE 44. BRAZIL NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 45. SAUDI ARABIA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 46. UAE NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 47. SOUTH AFRICA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
      TABLE 48. REST OF LAMEA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030,($MILLION)
    • LIST OF FIGURES

    • FIGURE 1.NEUROMONITORING DEVICES MARKET SEGMENTATION
      FIGURE 2.NEUROMONITORING DEVICES MARKET,2021-2030
      FIGURE 3.NEUROMONITORING DEVICES MARKET,2021-2030
      FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
      FIGURE 5.PORTER FIVE-1
      FIGURE 6.PORTER FIVE-2
      FIGURE 7.PORTER FIVE-3
      FIGURE 8.PORTER FIVE-4
      FIGURE 9.PORTER FIVE-5
      FIGURE 10.TOP PLAYER POSITIONING
      FIGURE 11.NEUROMONITORING DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
      FIGURE 12.REGULATORY GUIDELINES
      FIGURE 13.VALUE CHAIN ANALYSIS
      FIGURE 14.MARKET SHARE ANALYSIS
      FIGURE 15.KEY REGULATION ANALYSIS
      FIGURE 16.PATENT ANALYSIS BY COMPANY
      FIGURE 17.PATENT ANALYSIS BY COUNTRY
      FIGURE 18.NEUROMONITORING DEVICES MARKET,BY PRODUCT,2021(%)
      FIGURE 19.COMPARATIVE SHARE ANALYSIS OF INTRACRANIAL PRESSURE MONITORING NEUROMONITORING DEVICES MARKET,2021-2030(%)
      FIGURE 20.COMPARATIVE SHARE ANALYSIS OF CEREBRAL OXIMETER NEUROMONITORING DEVICES MARKET,2021-2030(%)
      FIGURE 21.COMPARATIVE SHARE ANALYSIS OF NEAR INFRARED SPECTROSCOPY NEUROMONITORING DEVICES MARKET,2021-2030(%)
      FIGURE 22.COMPARATIVE SHARE ANALYSIS OF SPECKLE IMAGING NEUROMONITORING DEVICES MARKET,2021-2030(%)
      FIGURE 23.COMPARATIVE SHARE ANALYSIS OF DOPPLER ULTRASOUND NEUROMONITORING DEVICES MARKET,2021-2030(%)
      FIGURE 24.COMPARATIVE SHARE ANALYSIS OF EEG NEUROMONITORING DEVICES MARKET,2021-2030(%)
      FIGURE 25.COMPARATIVE SHARE ANALYSIS OF FETAL/NEONATAL NEURO-MONITORING DEVICES NEUROMONITORING DEVICES MARKET,2021-2030(%)
      FIGURE 26.COMPARATIVE SHARE ANALYSIS OF MICRO ULTRASOUND NEUROMONITORING DEVICES MARKET,2021-2030(%)
      FIGURE 27.COMPARATIVE SHARE ANALYSIS OF OTHERS NEUROMONITORING DEVICES MARKET,2021-2030(%)
      FIGURE 28.NEUROMONITORING DEVICES MARKET BY REGION,2021
      FIGURE 29.U.S. NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 30.CANADA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 31.MEXICO NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 32.GERMANY NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 33.UNITED KINGDOM NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 34.FRANCE NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 35.SPAIN NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 36.ITALY NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 37.REST OF EUROPE NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 38.CHINA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 39.JAPAN NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 40.INDIA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 41.SOUTH KOREA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 42.AUSTRALIA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 43.REST OF ASIA PACIFIC NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 44.BRAZIL NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 45.SAUDI ARABIA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 46.UAE NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 47.SOUTH AFRICA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 48.REST OF LAMEA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
      FIGURE 49. TOP WINNING STRATEGIES, BY YEAR
      FIGURE 50. TOP WINNING STRATEGIES, BY DEVELOPMENT
      FIGURE 51. TOP WINNING STRATEGIES, BY COMPANY
      FIGURE 52.PRODUCT MAPPING OF TOP 10 PLAYERS
      FIGURE 53.COMPETITIVE DASHBOARD
      FIGURE 54.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

     
     

    According to the CXOs of the leading companies, the global neuromonitoring devices market possesses a substantial scope for growth in the future. Rapidly increasing neurological diseases like dementia and epilepsy among old age population are expected to accelerate the neuromonitoring devices market, globally. Also, increased rate of hospitalizations and emergency department admissions owing to serious health conditions and brain injury due to road accidents is further expected to increase the market revenue of neuromonitoring devices. Apart from this, introduction of wearable neuromonitoring devices to avoid unnecessary visits and hospitalizations is further expected to drive the market of neuromonitoring devices in the forecast time period. According to the CXOs, Asia-Pacific is projected to register faster growth as compared to North American and European markets

    PURCHASE OPTIONS

    Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

    Call or Email us

    U.S.-Canada
    Toll-free :
    +1-800-792-5285
    Int'l : +1-503-894-6022
    Europe : + 44-845-528-1300
    Email : help@alliedmarketresearch.com

    Looking for Customization

     Customization Request

    Have a question?

     Speak With Analyst

    Any Confusion?

     Inquire Before Buying

    Have a glance of Report?

     Request Sample
    FREQUENTLY ASKED QUESTIONS?
     

    A. Asia-Pacific will provide more business opportunities for global neuromonitoring devices market in the future.

    A. Agreement, business expansion, and product launch are the key growth strategies of global neuromonitoring devices market players.

    A. The increasing prevalence of neurological disorders such as dementia, epilepsy, and tumors is expected to drive the global neuromonitoring devices market. Furthermore, because of deteriorating immune systems and brain cell loss, the global geriatric population is expected to drive market growth and may create lucrative opportunities for the market.

    A. Doppler ultrasound segment held the maximum share of the global neuromonitoring devices market in 2021.

    A. GE Healthcare, Koninklijke Philips N.V., Medtronic Plc, Nihon Kohden Corporation, Natus Medical Incorporated., Nuvasive, Inc., Advanced Brain Monitoring, Inc., Intranerve Neuroscience Holdings, Llc, Specialtycare, and RIMED Ltd. in the neuromonitoring devices market.

    A. Hospitals and surgery centres include the major customers of global neuromonitoring devices market.

    A. The report provides an extensive qualitative and quantitative analysis of the current trends and future estimations of the global neuromonitoring devices market from 2021 to 2030 to determine the prevailing opportunities.

    A. Advances in the technology, developments, and product launches of new neuromonitoring devices in the market are projected to boost the market growth in the future. Major companies are continuously improving their existing products of neuromonitoring devices and launching new & advanced monitoring devices to cater the increasing demand for latest technology neuromonitoring devices. Such activities are anticipated to flourish the market in the projected time period, which will ultimately accelerate the global neuromonitoring devices market growth in the next few years.

    RELATED TAGS
     

    HAVE QUESTIONS?
    SPEAK WITH ANALYST

     

    DID YOU MISS ANYTHING?
    DO YOU HAVE SPECIFIC REQUIREMENTS?

     

    Download Sample

    OR

    Purchase Full Report of

    Start reading instantly.
    This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

    • Online Only
    • $3,456
    • Online cloud access only
    • Restricted print, copy, paste & download
    • Read only
    •   Free quarterly industry update
    •   Free report update (Within 180 days)
    •   Subscription model sign in
    • Data Pack
    • $3,840
    • Restricted to one authorized user
    • One print only
    • Available in
      Excel
    •   Free quarterly industry update
    •   Free report update (Within 180 days)
    •   Subscription model sign in
    • Single User
    • $6,168
    • Restricted to one authorized user
    • One print only
    • Available in Excel & PDF
    •   Free quarterly industry update
    •   Free report update (Within 180 days)
    •   Subscription model sign in
    • Five Users
    • $6,450
    • Limited to five authorized users
    • Print upto five copies
    • Available in Excel & PDF
    •   Free quarterly industry update
    •   Free report update (Within 180 days)
    •   Subscription model sign in
    • Enterprise
      License/PDF

    • $10,995
    • Unlimited
      within
      company/enterprise
    • Available in Excel & PDF
    •   Free quarterly industry update
    •   Free report update (Within 180 days)
    •   Subscription model sign in
    • Library Membership
    • $ 999
      Per User/ Per month/ Billed annually
    • Published Content
      E-access
    • Company Profiles
      E-access
    • Newly Added Content Access
    • 10 PDF
      Downloads
    • 5 Excel Data
      Pack Downloads
    • 250 Company Profiles PDF Downloads
    • Buy Now

    *Taxes/Fees, if applicable will be added during checkout. All prices in USD

     

    Why Allied Market Research?

     

    Infallible Methodology

    To ensure high-level data integrity, accurate analysis, and impeccable forecasts

    Analyst Support

    For complete satisfaction

    Customization

    On-demand customization of scope of the report to exactly meet your needs

    TARGETED MARKET VIEW

    Targeted market view to provide pertinent information and save time of readers

     
     

    Featured Reports

     

    Erythropoietin Drugs Market

    Global Opportunity Analysis and Industry Forecast, 2021–2028

    Published in May 2021

    Download Sample

    Protein Therapeutics Market

    Global Opportunity Analysis and Industry Forecast, 2021–2030

    Published in Feb 2022

    Download Sample

    Surgical Equipment Market

    Global Opportunity Analysis and Industry Forecast, 2020-2027

    Published in Jan 2021

    Download Sample

    Medical Implant Market

    Global Opportunity Analysis and Industry Forecast, 2020–2027

    Published in Nov 2020

    Download Sample

    Get fresh content delivered

    Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

     
    Get Industry Data Alerts
     

    Why Allied Market Research?

     

    Infallible Methodology

    To ensure high-level data integrity, accurate analysis, and impeccable forecasts

    Analyst Support

    For complete satisfaction

    Customization

    On-demand customization of scope of the report to exactly meet your needs

    TARGETED MARKET VIEW

    Targeted market view to provide pertinent information and save time of readers